Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 1 962 | déclaré | 02 janv. 2026 | tx 365+534 227−650 068 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 janv. 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 janv. 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1 962 | 0.00 USD | deriv |
| 02 janv. 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 166 | 0.00 USD | |
| 02 janv. 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1 958 | 0.00 USD | deriv |
| 23 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 707 | 625.60 USD | |
| 23 janv. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 2 707 | 950.00 USD | |
| 23 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 707 | 0.00 USD | deriv |
| 02 janv. 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 135 | 0.00 USD | |
| 02 janv. 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1 607 | 0.00 USD | deriv |
| 06 févr. 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 613 | 482.68 USD | |
| 06 févr. 2023 | SALE | REGENERON PHARMACEUTICALS, INC. | 3 613 | 800.00 USD | |
| 06 févr. 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 613 | 0.00 USD | deriv |
| 03 janv. 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 165 | 0.00 USD | |
| 03 janv. 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1 929 | 0.00 USD | deriv |
| 30 mars 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 431 | 374.12 USD | |
| 30 mars 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 2 431 | 700.00 USD | |
| 30 mars 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 431 | 0.00 USD | deriv |
| 03 janv. 2022 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 191 | 0.00 USD | |
| 03 janv. 2022 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2 707 | 0.00 USD | deriv |
| 10 sept. 2021 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 479 | 380.95 USD | |
| 10 sept. 2021 | SALE | REGENERON PHARMACEUTICALS, INC. | 2 479 | 650.00 USD | |
| 10 sept. 2021 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 479 | 0.00 USD | deriv |
| 07 juin 2021 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 930 | 374.12 USD | |
| 07 juin 2021 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 930 | 525.00 USD | |
| 07 juin 2021 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 930 | 0.00 USD | deriv |